Behavioral and immunohistochemical evidence for central antinociceptive activity of botulinum toxin A I Matak, L Bach-Rojecky, B Filipović, Z Lacković Neuroscience 186, 201-207, 2011 | 222 | 2011 |
Botulinum toxin A, brain and pain I Matak, Z Lacković Progress in neurobiology 119, 39-59, 2014 | 178 | 2014 |
Content of home pharmacies and self-medication practices in households of pharmacy and medical students in Zagreb, Croatia: findings in 2001 with a reference to 1977. V Aljinović-Vučić, V Trkulja, Z Lacković Croatian Medical Journal 46 (1), 2005 | 177 | 2005 |
Central origin of the antinociceptive action of botulinum toxin type A L Bach-Rojecky, Z Lacković Pharmacology Biochemistry and Behavior 94 (2), 234-238, 2009 | 163 | 2009 |
Botulinum toxin’s axonal transport from periphery to the spinal cord I Matak, P Riederer, Z Lacković Neurochemistry international 61 (2), 236-239, 2012 | 154 | 2012 |
Botulinum toxin type A reduces pain supersensitivity in experimental diabetic neuropathy: bilateral effect after unilateral injection L Bach-Rojecky, M Šalković-Petrišić, Z Lacković European journal of pharmacology 633 (1-3), 10-14, 2010 | 146 | 2010 |
Effect of long‐lasting diabetes mellitus on rat and human brain monoamines Z Lacković, M Šlković, Z Kuci, M Relja Journal of neurochemistry 54 (1), 143-147, 1990 | 146 | 1990 |
Botulinum toxin type A in experimental neuropathic pain L Bach-Rojecky, M Relja, Z Lacković Journal of neural transmission 112, 215-219, 2005 | 123 | 2005 |
Central action of peripherally applied botulinum toxin type A on pain and dural protein extravasation in rat model of trigeminal neuropathy B Filipović, I Matak, L Bach-Rojecky, Z Lacković PLoS one 7 (1), e29803, 2012 | 111 | 2012 |
Antinociceptive effect of botulinum toxin type a in rat model of carrageenan and capsaicin induced pain. L Bach-Rojecky, Z Lacković Croatian medical journal 46 (2), 2005 | 107 | 2005 |
Spinal cord serotonin: a biochemical and immunohistochemical study following transection M Hadjiconstantinou, P Panula, Z Lackovic, NH Neff Brain research 322 (2), 245-254, 1984 | 99 | 1984 |
Streptozotocin and alloxan produce alterations in rat brain monoamines independently of pancreatic beta cells destruction Z Lacković, M Šalković Life Sciences 46 (1), 49-54, 1990 | 80 | 1990 |
Simultaneous determination of femtomole quantities of 5-hydroxytryptophan, serotonin and 5-hydroxyindoleacetic acid in brain using HPLC with electrochemical detection Z Lacković, M Parenti, NH Neff European Journal of Pharmacology 69 (3), 347-352, 1981 | 76 | 1981 |
Botulinum toxin type A selectivity for certain types of pain is associated with capsaicin-sensitive neurons I Matak, O Rossetto, Z Lacković PAIN® 155 (8), 1516-1526, 2014 | 73 | 2014 |
Activity of botulinum toxin type A in cranial dura: implications for treatment of migraine and other headaches Z Lacković, B Filipović, I Matak, Z Helyes British journal of pharmacology 173 (2), 279-291, 2016 | 72 | 2016 |
Involvement of μ-opioid receptors in antinociceptive action of botulinum toxin type A V Drinovac, L Bach-Rojecky, I Matak, Z Lacković Neuropharmacology 70, 331-337, 2013 | 71 | 2013 |
Use of psychoactive substances among Zagreb University medical students: follow-up study. V Trkulja, Z Zivcec, M Cuk, Z Lacković Croatian medical journal 44 (1), 50-58, 2003 | 67 | 2003 |
Botulinum toxin type A in dental medicine VRM Muñoz Lora, AA Del Bel Cury, B Jabbari, Z Lacković Journal of dental research 98 (13), 1450-1457, 2019 | 66 | 2019 |
Reduced brain antioxidant capacity in rat models of betacytotoxic-induced experimental sporadic Alzheimer’s disease and diabetes mellitus I Tahirovic, E Sofic, A Sapcanin, I Gavrankapetanovic, L Bach-Rojecky, ... Neurochemical research 32, 1709-1717, 2007 | 66 | 2007 |
Croatian medicine in 1991 war against Croatia: a preliminary report Z Lackovic, J Markeljevic, M Marusic Croatian medical journal 2 (33), 110-119, 1992 | 65 | 1992 |